English

CYRUSONE INC.

EDGAR

CONE Annual report amendment (10-K/A) · filed 2022-03-23

146 filing records in this dataset, filed from 2012-08-08 to 2022-03-23. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

318 million USD

2021 Q4 · USD

Exact inputs and evidence

Revenue: 1205700000 USD Source
Revenue: 887300000 USD Source

Operating margin

-0.57%

2021 Q4 · %

Exact inputs and evidence

Operating Income: 39300000 USD Source
Operating Income: 41100000 USD Source
Revenue: 1205700000 USD Source
Revenue: 887300000 USD Source

Operating cash flow

88.2 million USD

2021 Q4 · USD

Exact inputs and evidence

Operating Cash Flow: 477600000 USD Source
Operating Cash Flow: 389400000 USD Source

Cash and cash equivalents: 346 million USD 2021-12-31 Source
Exact value

346300000 USD
Long-term debt including current maturities: 3.49 billion USD 2021-12-31 Source
Exact value

3492900000 USD
Shares outstanding: 130 million shares 2021-12-31 Source
Exact value

129600000 shares

Reported share-count change

7.60% · 9.16 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

120442521 shares · 2020-12-31· Source
129600000 shares · 2021-12-31· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

1.21 billion USD

2021-01-01 – 2021-12-31

Exact inputs and evidence

Revenue: 298600000 USD · 2021-01-01 – 2021-03-31 Source
Revenue: 284600000 USD · 2021-04-01 – 2021-06-30 Source
Revenue: 304100000 USD · 2021-07-01 – 2021-09-30 Source
Revenue: 1205700000 USD · 2021-01-01 – 2021-12-31 Source
Revenue: 887300000 USD · 2021-01-01 – 2021-09-30 Source

Net income

25.3 million USD

2021-01-01 – 2021-12-31

Exact inputs and evidence

Net income: 18200000 USD · 2021-01-01 – 2021-03-31 Source
Net income: 7400000 USD · 2021-04-01 – 2021-06-30 Source
Net income: 6700000 USD · 2021-07-01 – 2021-09-30 Source
Net income: 25300000 USD · 2021-01-01 – 2021-12-31 Source
Net income: 32300000 USD · 2021-01-01 – 2021-09-30 Source

Operating cash flow

478 million USD

2021-01-01 – 2021-12-31

Exact inputs and evidence

Operating cash flow: 106700000 USD · 2021-01-01 – 2021-03-31 Source
Operating cash flow: 226100000 USD · 2021-01-01 – 2021-06-30 Source
Operating cash flow: 106700000 USD · 2021-01-01 – 2021-03-31 Source
Operating cash flow: 389400000 USD · 2021-01-01 – 2021-09-30 Source
Operating cash flow: 226100000 USD · 2021-01-01 – 2021-06-30 Source
Operating cash flow: 477600000 USD · 2021-01-01 – 2021-12-31 Source
Operating cash flow: 389400000 USD · 2021-01-01 – 2021-09-30 Source

Capital expenditure

203 million USD

2018-07-01 – 2019-06-30

Exact inputs and evidence

Capital expenditure: 139900000 USD · 2018-07-01 – 2018-09-30 Source
Capital expenditure: 182300000 USD · 2018-01-01 – 2018-12-31 Source
Capital expenditure: 159600000 USD · 2018-01-01 – 2018-09-30 Source
Capital expenditure: 40100000 USD · 2019-01-01 – 2019-03-31 Source
Capital expenditure: 40100000 USD · 2019-01-01 – 2019-06-30 Source
Capital expenditure: 40100000 USD · 2019-01-01 – 2019-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2022-03-23.

Financial data available through: 2021-12-31.

Coverage by financial measure

Revenue: 9 of 11 periods available· newest 2021-12-31
Operating income: 9 of 11 periods available· newest 2021-12-31
Net income: 9 of 11 periods available· newest 2021-12-31
Operating cash flow: 9 of 11 periods available· newest 2021-12-31
Capital expenditure: 2 of 11 periods available· newest 2018-12-31
Total assets: 9 of 11 periods available· newest 2021-12-31
Total liabilities: 9 of 11 periods available· newest 2021-12-31
current assets: No compatible figures in this window
current liabilities: No compatible figures in this window
Cash and cash equivalents: 9 of 11 periods available· newest 2021-12-31
Long-term debt including current maturities: 9 of 11 periods available· newest 2021-12-31
Shares outstanding: 8 of 11 periods available· newest 2021-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+16.7%

Prior period

USD 1.03 billion

2020-01-01 – 2020-12-31
Current period

USD 1.21 billion

2021-01-01 – 2021-12-31

Exact inputs and evidence

1205700000 − 1033500000 = 172200000 USD

1033500000 USD · 2020-01-01 – 2020-12-31
Inspect prior input Prior source
1205700000 USD · 2021-01-01 – 2021-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · CYRUSONE INC. · 2021-12-31 CYRUSONE INC. (edgar:1553023) Year-over-year change in Revenue: 172200000 USD Concept: fundies:Revenue Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T13:37:27Z Snapshot: ed592d70b77622b98464f5942aea7cb7841e582a766f266a2669775e8a1fc943 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1553023?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 1205700000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1553023/000155302322000009/cone-20211231.htm#2116290 Filing: 000155302322000009 Input fundies:Revenue: 1033500000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1553023/000155302322000009/cone-20211231.htm#2116825 Filing: 000155302322000009
The citation records this snapshot. The page link may show a newer release later.
Net income
-38.9%

Prior period

USD 41.4 million

2020-01-01 – 2020-12-31
Current period

USD 25.3 million

2021-01-01 – 2021-12-31

Exact inputs and evidence

25300000 − 41400000 = -16100000 USD

41400000 USD · 2020-01-01 – 2020-12-31
Inspect prior input Prior source
25300000 USD · 2021-01-01 – 2021-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · CYRUSONE INC. · 2021-12-31 CYRUSONE INC. (edgar:1553023) Year-over-year change in Net income: -16100000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T13:37:27Z Snapshot: ed592d70b77622b98464f5942aea7cb7841e582a766f266a2669775e8a1fc943 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1553023?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 25300000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1553023/000155302322000009/cone-20211231.htm#2725670 Filing: 000155302322000009 Input fundies:NetIncome: 41400000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1553023/000155302322000009/cone-20211231.htm#2727814 Filing: 000155302322000009
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+4.7%

Prior period

USD 456.3 million

2020-01-01 – 2020-12-31
Current period

USD 477.6 million

2021-01-01 – 2021-12-31

Exact inputs and evidence

477600000 − 456300000 = 21300000 USD

456300000 USD · 2020-01-01 – 2020-12-31
Inspect prior input Prior source
477600000 USD · 2021-01-01 – 2021-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · CYRUSONE INC. · 2021-12-31 CYRUSONE INC. (edgar:1553023) Year-over-year change in Operating cash flow: 21300000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T13:37:27Z Snapshot: ed592d70b77622b98464f5942aea7cb7841e582a766f266a2669775e8a1fc943 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1553023?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 477600000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1553023/000155302322000009/cone-20211231.htm#1951477 Filing: 000155302322000009 Input fundies:OperatingCashFlow: 456300000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1553023/000155302322000009/cone-20211231.htm#1952429 Filing: 000155302322000009
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2021 2021-01-01 – 2021-12-31

Revenue USD 1.21 billion 100% of revenue
Operating costs Derived USD 1.17 billion 97% of revenue
Operating income USD 39.3 million 3.3% of revenue
Tax, interest and other Derived USD 14 million 1.2% of revenue
Net income USD 25.3 million 2.1% of revenue

Cash

Operating cash flow USD 477.6 million 40% of revenue
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2013 Net loss: net income was −2% of revenue.
2013 Net loss: net income was −2.1% of revenue.
2014 Net loss: net income was −2.4% of revenue.
2015 Net loss: net income was −3.9% of revenue.
2016 9.6%87%
2017 Net loss: net income was −12% of revenue.
2018 11%89%
2019 93%
2020 Net income was higher than operating income, so the split is not drawn.
2021 97%

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2013 2013-01-01 – 2013-12-31	263500000	251900000 Derived	11600000	16900000 Derived	-5300000	Unavailable	Source 2013-01-01 – 2013-12-31: 263500000 USD Inspect Revenue Open source 2013-01-01 – 2013-12-31: 11600000 USD Inspect Operating Income Open source 2013-01-01 – 2013-12-31: -5300000 USD Inspect Net Income Open source
2013 2013-01-24 – 2013-12-31	248400000	219500000 Derived	28900000	34200000 Derived	-5300000	Unavailable	Source 2013-01-24 – 2013-12-31: 248400000 USD Inspect Revenue Open source 2013-01-24 – 2013-12-31: 28900000 USD Inspect Operating Income Open source 2013-01-24 – 2013-12-31: -5300000 USD Inspect Net Income Open source 2013-01-24 – 2013-12-31: 77400000 USD Inspect Operating Cash Flow Open source
2014 2014-01-01 – 2014-12-31	330900000	290900000 Derived	40000000	47800000 Derived	-7800000	Unavailable	Source 2014-01-01 – 2014-12-31: 330900000 USD Inspect Revenue Open source 2014-01-01 – 2014-12-31: 40000000 USD Inspect Operating Income Open source 2014-01-01 – 2014-12-31: -7800000 USD Inspect Net Income Open source 2014-01-01 – 2014-12-31: 111100000 USD Inspect Operating Cash Flow Open source
2015 2015-01-01 – 2015-12-31	399300000	376500000 Derived	22800000	38200000 Derived	-15400000	Unavailable	Source 2015-01-01 – 2015-12-31: 399300000 USD Inspect Revenue Open source 2015-01-01 – 2015-12-31: 22800000 USD Inspect Operating Income Open source 2015-01-01 – 2015-12-31: -15400000 USD Inspect Net Income Open source 2015-01-01 – 2015-12-31: 140200000 USD Inspect Operating Cash Flow Open source
2016 2016-01-01 – 2016-12-31	529100000	458600000 Derived	70500000	50600000 Derived	19900000	Unavailable	Source 2016-01-01 – 2016-12-31: 529100000 USD Inspect Revenue Open source 2016-01-01 – 2016-12-31: 70500000 USD Inspect Operating Income Open source 2016-01-01 – 2016-12-31: 19900000 USD Inspect Net Income Open source 2016-01-01 – 2016-12-31: 180600000 USD Inspect Operating Cash Flow Open source
2017 2017-01-01 – 2017-12-31	672000000	647900000 Derived	24100000	107600000 Derived	-83500000	254200000 Derived	Source 2017-01-01 – 2017-12-31: 672000000 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: 24100000 USD Inspect Operating Income Open source 2017-01-01 – 2017-12-31: -83500000 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: 289500000 USD Inspect Operating Cash Flow Open source 2017-01-01 – 2017-12-31: 35300000 USD Inspect Capital Expenditure Open source
2018 2018-01-01 – 2018-12-31	821400000	731700000 Derived	89700000	88500000 Derived	1200000	127000000 Derived	Source 2018-01-01 – 2018-12-31: 821400000 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: 89700000 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: 1200000 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: 309300000 USD Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 182300000 USD Inspect Capital Expenditure Open source
2019 2019-01-01 – 2019-12-31	981300000	914300000 Derived	67000000	25600000 Derived	41400000	Unavailable	Source 2019-01-01 – 2019-12-31: 981300000 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: 67000000 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: 41400000 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: 365700000 USD Inspect Operating Cash Flow Open source
2020 2020-01-01 – 2020-12-31	1033500000	993400000 Derived	40100000	-1300000 Derived	41400000	Unavailable	Source 2020-01-01 – 2020-12-31: 1033500000 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: 40100000 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: 41400000 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: 456300000 USD Inspect Operating Cash Flow Open source
2021 2021-01-01 – 2021-12-31	1205700000	1166400000 Derived	39300000	14000000 Derived	25300000	Unavailable	Source 2021-01-01 – 2021-12-31: 1205700000 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: 39300000 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: 25300000 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: 477600000 USD Inspect Operating Cash Flow Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 1.2B 2021

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20142014-12-31	Revenue	330900000	Revenue: 330900000 Open source
20152015-12-31	Revenue	399300000	Revenue: 399300000 Open source
20162016-12-31	Revenue	529100000	Revenue: 529100000 Open source
20172017-12-31	Revenue	672000000	Revenue: 672000000 Open source
20182018-12-31	Revenue	821400000	Revenue: 821400000 Open source
20192019-12-31	Revenue	981300000	Revenue: 981300000 Open source
20202020-12-31	Revenue	1033500000	Revenue: 1033500000 Open source
20212021-12-31	Revenue	1205700000	Revenue: 1205700000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

16.7% 2021

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20142014-12-31	Year over year	No prior comparable period	Revenue: 330900000 Open source
20152015-12-31	Year over year	20.7%	Revenue: 399300000 Open source Revenue: 330900000 Open source
20162016-12-31	Year over year	32.5%	Revenue: 529100000 Open source Revenue: 399300000 Open source
20172017-12-31	Year over year	27%	Revenue: 672000000 Open source Revenue: 529100000 Open source
20182018-12-31	Year over year	22.2%	Revenue: 821400000 Open source Revenue: 672000000 Open source
20192019-12-31	Year over year	19.5%	Revenue: 981300000 Open source Revenue: 821400000 Open source
20202020-12-31	Year over year	5.3%	Revenue: 1033500000 Open source Revenue: 981300000 Open source
20212021-12-31	Year over year	16.7%	Revenue: 1205700000 Open source Revenue: 1033500000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 3.3% 2021

Net margin 2.1% 2021

Free cash flow margin 15.5% 2018

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20142014-12-31	Operating margin	12.1%	Operating Income: 40000000 Open source Revenue: 330900000 Open source
20152015-12-31	Operating margin	5.7%	Operating Income: 22800000 Open source Revenue: 399300000 Open source
20162016-12-31	Operating margin	13.3%	Operating Income: 70500000 Open source Revenue: 529100000 Open source
20172017-12-31	Operating margin	3.6%	Operating Income: 24100000 Open source Revenue: 672000000 Open source
20182018-12-31	Operating margin	10.9%	Operating Income: 89700000 Open source Revenue: 821400000 Open source
20192019-12-31	Operating margin	6.8%	Operating Income: 67000000 Open source Revenue: 981300000 Open source
20202020-12-31	Operating margin	3.9%	Operating Income: 40100000 Open source Revenue: 1033500000 Open source
20212021-12-31	Operating margin	3.3%	Operating Income: 39300000 Open source Revenue: 1205700000 Open source
20142014-12-31	Net margin	-2.4%	Net Income: -7800000 Open source Revenue: 330900000 Open source
20152015-12-31	Net margin	-3.9%	Net Income: -15400000 Open source Revenue: 399300000 Open source
20162016-12-31	Net margin	3.8%	Net Income: 19900000 Open source Revenue: 529100000 Open source
20172017-12-31	Net margin	-12.4%	Net Income: -83500000 Open source Revenue: 672000000 Open source
20182018-12-31	Net margin	0.1%	Net Income: 1200000 Open source Revenue: 821400000 Open source
20192019-12-31	Net margin	4.2%	Net Income: 41400000 Open source Revenue: 981300000 Open source
20202020-12-31	Net margin	4%	Net Income: 41400000 Open source Revenue: 1033500000 Open source
20212021-12-31	Net margin	2.1%	Net Income: 25300000 Open source Revenue: 1205700000 Open source
20142014-12-31	Free cash flow margin	Not reported	Revenue: 330900000 Open source Operating Cash Flow: 111100000 Open source
20152015-12-31	Free cash flow margin	Not reported	Revenue: 399300000 Open source Operating Cash Flow: 140200000 Open source
20162016-12-31	Free cash flow margin	Not reported	Revenue: 529100000 Open source Operating Cash Flow: 180600000 Open source
20172017-12-31	Free cash flow margin	37.8%	Revenue: 672000000 Open source Operating Cash Flow: 289500000 Open source Capital Expenditure: 35300000 Open source
20182018-12-31	Free cash flow margin	15.5%	Revenue: 821400000 Open source Operating Cash Flow: 309300000 Open source Capital Expenditure: 182300000 Open source
20192019-12-31	Free cash flow margin	Not reported	Revenue: 981300000 Open source Operating Cash Flow: 365700000 Open source
20202020-12-31	Free cash flow margin	Not reported	Revenue: 1033500000 Open source Operating Cash Flow: 456300000 Open source
20212021-12-31	Free cash flow margin	Not reported	Revenue: 1205700000 Open source Operating Cash Flow: 477600000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 477.6M 2021

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20142014-12-31	Operating cash flow	111100000	Operating Cash Flow: 111100000 Open source
20152015-12-31	Operating cash flow	140200000	Operating Cash Flow: 140200000 Open source
20162016-12-31	Operating cash flow	180600000	Operating Cash Flow: 180600000 Open source
20172017-12-31	Operating cash flow	289500000	Operating Cash Flow: 289500000 Open source
20182018-12-31	Operating cash flow	309300000	Operating Cash Flow: 309300000 Open source
20192019-12-31	Operating cash flow	365700000	Operating Cash Flow: 365700000 Open source
20202020-12-31	Operating cash flow	456300000	Operating Cash Flow: 456300000 Open source
20212021-12-31	Operating cash flow	477600000	Operating Cash Flow: 477600000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 127M 2018

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20142014-12-31	Free cash flow	Unavailable	Operating Cash Flow: 111100000 Open source
20152015-12-31	Free cash flow	Unavailable	Operating Cash Flow: 140200000 Open source
20162016-12-31	Free cash flow	Unavailable	Operating Cash Flow: 180600000 Open source
20172017-12-31	Free cash flow	254200000	Operating Cash Flow: 289500000 Open source Capital Expenditure: 35300000 Open source
20182018-12-31	Free cash flow	127000000	Operating Cash Flow: 309300000 Open source Capital Expenditure: 182300000 Open source
20192019-12-31	Free cash flow	Unavailable	Operating Cash Flow: 365700000 Open source
20202020-12-31	Free cash flow	Unavailable	Operating Cash Flow: 456300000 Open source
20212021-12-31	Free cash flow	Unavailable	Operating Cash Flow: 477600000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

60.8% 2021

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20142014-12-31	Liabilities / assets	54.4%	Total Liabilities: 854000000 Open source Total Assets: 1571000000 Open source
20152015-12-31	Liabilities / assets	62.6%	Total Liabilities: 1374000000 Open source Total Assets: 2195600000 Open source
20162016-12-31	Liabilities / assets	59.3%	Total Liabilities: 1690400000 Open source Total Assets: 2852400000 Open source
20172017-12-31	Liabilities / assets	60.3%	Total Liabilities: 2598200000 Open source Total Assets: 4312100000 Open source
20182018-12-31	Liabilities / assets	60.2%	Total Liabilities: 3366500000 Open source Total Assets: 5592500000 Open source
20192019-12-31	Liabilities / assets	60.4%	Total Liabilities: 3707400000 Open source Total Assets: 6142000000 Open source
20202020-12-31	Liabilities / assets	62.9%	Total Liabilities: 4339200000 Open source Total Assets: 6897400000 Open source
20212021-12-31	Liabilities / assets	60.8%	Total Liabilities: 4528300000 Open source Total Assets: 7452000000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
2014-12-31	Current assets / current liabilities	Not reported	No source recorded
2015-12-31	Current assets / current liabilities	Not reported	No source recorded
2016-12-31	Current assets / current liabilities	Not reported	No source recorded
2017-12-31	Current assets / current liabilities	Not reported	No source recorded
2018-12-31	Current assets / current liabilities	Not reported	No source recorded
2019-12-31	Current assets / current liabilities	Not reported	No source recorded
2020-12-31	Current assets / current liabilities	Not reported	No source recorded
2021-12-31	Current assets / current liabilities	Not reported	No source recorded

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2013 2013-01-01 – 2013-12-31	−USD 5.3 million Exact value Exact value: -5300000 USD 2013-01-01 – 2013-12-31: -5300000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CYRUSONE INC. · 2013-12-31 CYRUSONE INC. (edgar:1553023) Net Income: -5300000 USD Concept: fundies:NetIncome Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T13:37:27Z Snapshot: ed592d70b77622b98464f5942aea7cb7841e582a766f266a2669775e8a1fc943 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1553023/explain?concept=fundies%3ANetIncome&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:NetIncome: -5300000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1553023/000155302316000152/cone-20151231.xml#815451 Filing: 000155302316000152 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.
2013 2013-01-24 – 2013-12-31	−USD 5.3 million Exact value Exact value: -5300000 USD 2013-01-24 – 2013-12-31: -5300000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CYRUSONE INC. · 2013-12-31 CYRUSONE INC. (edgar:1553023) Net Income: -5300000 USD Concept: fundies:NetIncome Period: 2013-01-24 to 2013-12-31 Values: Latest reported Published: 2026-11-02T13:37:27Z Snapshot: ed592d70b77622b98464f5942aea7cb7841e582a766f266a2669775e8a1fc943 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1553023/explain?concept=fundies%3ANetIncome&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-24&unit=USD&dimensions= Input fundies:NetIncome: -5300000 USD (2013-01-24 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1553023/000155302316000152/cone-20151231.xml#813448 Filing: 000155302316000152 The citation records this snapshot. The page link may show a newer release later.	USD 77.4 million Exact value Exact value: 77400000 USD 2013-01-24 – 2013-12-31: 77400000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CYRUSONE INC. · 2013-12-31 CYRUSONE INC. (edgar:1553023) Operating Cash Flow: 77400000 USD Concept: fundies:OperatingCashFlow Period: 2013-01-24 to 2013-12-31 Values: Latest reported Published: 2026-11-02T13:37:27Z Snapshot: ed592d70b77622b98464f5942aea7cb7841e582a766f266a2669775e8a1fc943 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1553023/explain?concept=fundies%3AOperatingCashFlow&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-24&unit=USD&dimensions= Input fundies:OperatingCashFlow: 77400000 USD (2013-01-24 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1553023/000155302316000152/cone-20151231.xml#806267 Filing: 000155302316000152 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2014 2014-01-01 – 2014-12-31	−USD 7.8 million Exact value Exact value: -7800000 USD 2014-01-01 – 2014-12-31: -7800000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CYRUSONE INC. · 2014-12-31 CYRUSONE INC. (edgar:1553023) Net Income: -7800000 USD Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T13:37:27Z Snapshot: ed592d70b77622b98464f5942aea7cb7841e582a766f266a2669775e8a1fc943 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1553023/explain?concept=fundies%3ANetIncome&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:NetIncome: -7800000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1553023/000155302317000059/cone-20161231.xml#696474 Filing: 000155302317000059 The citation records this snapshot. The page link may show a newer release later.	USD 111.1 million Exact value Exact value: 111100000 USD 2014-01-01 – 2014-12-31: 111100000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CYRUSONE INC. · 2014-12-31 CYRUSONE INC. (edgar:1553023) Operating Cash Flow: 111100000 USD Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T13:37:27Z Snapshot: ed592d70b77622b98464f5942aea7cb7841e582a766f266a2669775e8a1fc943 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1553023/explain?concept=fundies%3AOperatingCashFlow&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 111100000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1553023/000155302317000059/cone-20161231.xml#690275 Filing: 000155302317000059 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2015 2015-01-01 – 2015-12-31	−USD 15.4 million Exact value Exact value: -15400000 USD 2015-01-01 – 2015-12-31: -15400000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CYRUSONE INC. · 2015-12-31 CYRUSONE INC. (edgar:1553023) Net Income: -15400000 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T13:37:27Z Snapshot: ed592d70b77622b98464f5942aea7cb7841e582a766f266a2669775e8a1fc943 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1553023/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:NetIncome: -15400000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1553023/000155302318000029/cone-20171231.xml#756997 Filing: 000155302318000029 The citation records this snapshot. The page link may show a newer release later.	USD 140.2 million Exact value Exact value: 140200000 USD 2015-01-01 – 2015-12-31: 140200000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CYRUSONE INC. · 2015-12-31 CYRUSONE INC. (edgar:1553023) Operating Cash Flow: 140200000 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T13:37:27Z Snapshot: ed592d70b77622b98464f5942aea7cb7841e582a766f266a2669775e8a1fc943 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1553023/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 140200000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1553023/000155302318000029/cone-20171231.xml#750603 Filing: 000155302318000029 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2016 2016-01-01 – 2016-12-31	USD 19.9 million Exact value Exact value: 19900000 USD 2016-01-01 – 2016-12-31: 19900000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CYRUSONE INC. · 2016-12-31 CYRUSONE INC. (edgar:1553023) Net Income: 19900000 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T13:37:27Z Snapshot: ed592d70b77622b98464f5942aea7cb7841e582a766f266a2669775e8a1fc943 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1553023/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: 19900000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1553023/000155302319000040/cone-20181231.xml#725374 Filing: 000155302319000040 The citation records this snapshot. The page link may show a newer release later.	USD 180.6 million Exact value Exact value: 180600000 USD 2016-01-01 – 2016-12-31: 180600000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CYRUSONE INC. · 2016-12-31 CYRUSONE INC. (edgar:1553023) Operating Cash Flow: 180600000 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T13:37:27Z Snapshot: ed592d70b77622b98464f5942aea7cb7841e582a766f266a2669775e8a1fc943 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1553023/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 180600000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1553023/000155302319000040/cone-20181231.xml#719096 Filing: 000155302319000040 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2017 2017-01-01 – 2017-12-31	−USD 83.5 million Exact value Exact value: -83500000 USD 2017-01-01 – 2017-12-31: -83500000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CYRUSONE INC. · 2017-12-31 CYRUSONE INC. (edgar:1553023) Net Income: -83500000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T13:37:27Z Snapshot: ed592d70b77622b98464f5942aea7cb7841e582a766f266a2669775e8a1fc943 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1553023/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -83500000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1553023/000155302320000025/cone-20191231x10k.htm#4288702 Filing: 000155302320000025 The citation records this snapshot. The page link may show a newer release later.	USD 289.5 million Exact value Exact value: 289500000 USD 2017-01-01 – 2017-12-31: 289500000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CYRUSONE INC. · 2017-12-31 CYRUSONE INC. (edgar:1553023) Operating Cash Flow: 289500000 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T13:37:27Z Snapshot: ed592d70b77622b98464f5942aea7cb7841e582a766f266a2669775e8a1fc943 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1553023/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 289500000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1553023/000155302320000025/cone-20191231x10k.htm#4639136 Filing: 000155302320000025 The citation records this snapshot. The page link may show a newer release later.	USD 35.3 million Exact value Exact value: 35300000 USD 2017-01-01 – 2017-12-31: 35300000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CYRUSONE INC. · 2017-12-31 CYRUSONE INC. (edgar:1553023) Capital Expenditure: 35300000 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T13:37:27Z Snapshot: ed592d70b77622b98464f5942aea7cb7841e582a766f266a2669775e8a1fc943 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1553023/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 35300000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1553023/000155302319000040/cone-20181231.xml#800194 Filing: 000155302319000040 The citation records this snapshot. The page link may show a newer release later.	USD 254.2 million Calculation and evidence 289500000 − 35300000 USD Exact free cash flow: 254200000 USD 2017-01-01 – 2017-12-31: 289500000 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 35300000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CYRUSONE INC. · 2017-12-31 CYRUSONE INC. (edgar:1553023) Free cash flow: 254200000 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T13:37:27Z Snapshot: ed592d70b77622b98464f5942aea7cb7841e582a766f266a2669775e8a1fc943 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1553023?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 289500000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1553023/000155302320000025/cone-20191231x10k.htm#4639136 Filing: 000155302320000025 Input fundies:CapitalExpenditure: 35300000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1553023/000155302319000040/cone-20181231.xml#800194 Filing: 000155302319000040 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	USD 1.2 million Exact value Exact value: 1200000 USD 2018-01-01 – 2018-12-31: 1200000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CYRUSONE INC. · 2018-12-31 CYRUSONE INC. (edgar:1553023) Net Income: 1200000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T13:37:27Z Snapshot: ed592d70b77622b98464f5942aea7cb7841e582a766f266a2669775e8a1fc943 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1553023/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: 1200000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1553023/000155302321000012/cone-20201231.htm#2776190 Filing: 000155302321000012 The citation records this snapshot. The page link may show a newer release later.	USD 309.3 million Exact value Exact value: 309300000 USD 2018-01-01 – 2018-12-31: 309300000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CYRUSONE INC. · 2018-12-31 CYRUSONE INC. (edgar:1553023) Operating Cash Flow: 309300000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T13:37:27Z Snapshot: ed592d70b77622b98464f5942aea7cb7841e582a766f266a2669775e8a1fc943 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1553023/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 309300000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1553023/000155302321000012/cone-20201231.htm#1964280 Filing: 000155302321000012 The citation records this snapshot. The page link may show a newer release later.	USD 182.3 million Exact value Exact value: 182300000 USD 2018-01-01 – 2018-12-31: 182300000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CYRUSONE INC. · 2018-12-31 CYRUSONE INC. (edgar:1553023) Capital Expenditure: 182300000 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T13:37:27Z Snapshot: ed592d70b77622b98464f5942aea7cb7841e582a766f266a2669775e8a1fc943 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1553023/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 182300000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1553023/000155302319000040/cone-20181231.xml#800405 Filing: 000155302319000040 The citation records this snapshot. The page link may show a newer release later.	USD 127 million Calculation and evidence 309300000 − 182300000 USD Exact free cash flow: 127000000 USD 2018-01-01 – 2018-12-31: 309300000 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 182300000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CYRUSONE INC. · 2018-12-31 CYRUSONE INC. (edgar:1553023) Free cash flow: 127000000 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T13:37:27Z Snapshot: ed592d70b77622b98464f5942aea7cb7841e582a766f266a2669775e8a1fc943 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1553023?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 309300000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1553023/000155302321000012/cone-20201231.htm#1964280 Filing: 000155302321000012 Input fundies:CapitalExpenditure: 182300000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1553023/000155302319000040/cone-20181231.xml#800405 Filing: 000155302319000040 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	USD 41.4 million Exact value Exact value: 41400000 USD 2019-01-01 – 2019-12-31: 41400000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CYRUSONE INC. · 2019-12-31 CYRUSONE INC. (edgar:1553023) Net Income: 41400000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T13:37:27Z Snapshot: ed592d70b77622b98464f5942aea7cb7841e582a766f266a2669775e8a1fc943 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1553023/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: 41400000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1553023/000155302322000009/cone-20211231.htm#2729958 Filing: 000155302322000009 The citation records this snapshot. The page link may show a newer release later.	USD 365.7 million Exact value Exact value: 365700000 USD 2019-01-01 – 2019-12-31: 365700000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CYRUSONE INC. · 2019-12-31 CYRUSONE INC. (edgar:1553023) Operating Cash Flow: 365700000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T13:37:27Z Snapshot: ed592d70b77622b98464f5942aea7cb7841e582a766f266a2669775e8a1fc943 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1553023/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 365700000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1553023/000155302322000009/cone-20211231.htm#1953381 Filing: 000155302322000009 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2020 2020-01-01 – 2020-12-31	USD 41.4 million Exact value Exact value: 41400000 USD 2020-01-01 – 2020-12-31: 41400000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CYRUSONE INC. · 2020-12-31 CYRUSONE INC. (edgar:1553023) Net Income: 41400000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T13:37:27Z Snapshot: ed592d70b77622b98464f5942aea7cb7841e582a766f266a2669775e8a1fc943 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1553023/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: 41400000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1553023/000155302322000009/cone-20211231.htm#2727814 Filing: 000155302322000009 The citation records this snapshot. The page link may show a newer release later.	USD 456.3 million Exact value Exact value: 456300000 USD 2020-01-01 – 2020-12-31: 456300000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CYRUSONE INC. · 2020-12-31 CYRUSONE INC. (edgar:1553023) Operating Cash Flow: 456300000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T13:37:27Z Snapshot: ed592d70b77622b98464f5942aea7cb7841e582a766f266a2669775e8a1fc943 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1553023/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 456300000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1553023/000155302322000009/cone-20211231.htm#1952429 Filing: 000155302322000009 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2021 2021-01-01 – 2021-12-31	USD 25.3 million Exact value Exact value: 25300000 USD 2021-01-01 – 2021-12-31: 25300000 USD Inspect Net Income Open source Share or cite Citation for Net Income · CYRUSONE INC. · 2021-12-31 CYRUSONE INC. (edgar:1553023) Net Income: 25300000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T13:37:27Z Snapshot: ed592d70b77622b98464f5942aea7cb7841e582a766f266a2669775e8a1fc943 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1553023/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: 25300000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1553023/000155302322000009/cone-20211231.htm#2725670 Filing: 000155302322000009 The citation records this snapshot. The page link may show a newer release later.	USD 477.6 million Exact value Exact value: 477600000 USD 2021-01-01 – 2021-12-31: 477600000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CYRUSONE INC. · 2021-12-31 CYRUSONE INC. (edgar:1553023) Operating Cash Flow: 477600000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T13:37:27Z Snapshot: ed592d70b77622b98464f5942aea7cb7841e582a766f266a2669775e8a1fc943 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1553023/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 477600000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1553023/000155302322000009/cone-20211231.htm#1951477 Filing: 000155302322000009 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

146 filings · 2,399 latest values · 2,399 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001553023, 1553023, CONE, edgar:1553023

Also known as CYRUSONE INC., CyrusOne Holdco LLC, CyrusOne Inc.

CYRUSONE INC.

Latest quarter

Revenue

Operating margin

Operating cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Where revenue goes

2021 2021-01-01 – 2021-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation